Top Clinical Trials companies in Italy by EBITDA Margin

This ranking features the top 2 Clinical Trials companies in Italy ranked by EBITDA Margin, averaging a EBITDA Margin of -69.13%, for February 07, 2025.

Italy

Clinical Trials
EBITDA Margin
#
Name
EBITDA Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
PHIL.MI

Philogen S.p.A.

1

PHIL.MI
-8.85%
Dec. 31, 2023 USD 19.11 -0.17%

Italy
2
NP5.DE

Newron Pharmaceuticals S.p.A.

2

NP5.DE
-129.40%
Dec. 31, 2023 USD 10.99 1.17%

Italy
Frequently Asked Questions
  • Which Clinical Trials company in Italy has the highest EBITDA Margin ?

    The Clinical Trials company in Italy with the highest EBITDA Margin is Philogen S.p.A. (Milan Stock Exchange: PHIL.MI) at -8.85%.

  • Which Clinical Trials company in Italy has the lowest EBITDA Margin ?

    The Clinical Trials company in Italy with the lowest EBITDA Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -129.40%.

SV Wall Street